Nonetheless, experimental studies have shown that the use of anti-TNF-α iseffective in the treatment of chemically induced colitis and to the best of ourknowledge to date the use of anti-TNF-α (infliximab) has never been evaluated inexperimental models experimental or patients with the severe forms of DC, whichmakes this study a pioneer. The gene discussed is TNF; the disease is colitis.